In the one placebo-controlled trial of PRP for ankle arthritis, 100 patients reported in JAMA, PRP did no better than saline at 26 weeks or at the 52-week follow-up. A 2026 review that searched to May 2025 found no randomized trial of stem cell injection in ankle arthritis. In chronic ankle instability, a 47-person trial with no placebo arm found PRP alone gave the greatest pain drop, and PRP with exercise or a no-injection manual therapy gave broader gains in posture and function. For talar cartilage lesions, PRP and cell-based treatments are studied largely alongside surgery. In Boulder, Colorado, Aneesh Garg, DO, CAQ performs every PRP and stem cell injection himself, under live ultrasound.
You want the trail back: the ridge run, the long hike without watching every step. If your ankle has rolled for years, or has ached since an old fracture, this page sorts what PRP and stem cells can and cannot do for it before anyone says fusion or replacement.
Four questions, and what the trials actually found
The ankle that keeps rolling: PRP for the pain, rehab for the stability
After a lateral sprain, 20% to 40% of athletes develop persistent pain, recurrent sprains or chronic instability, a 2026 trial of 40 athletes notes. There, three PRP injections added to RICE and physiotherapy did not improve pain or function scores at 6 or 12 months; time to unrestricted sport was shorter, 14.5 against 17.8 weeks, a result the authors called exploratory and underpowered. In chronic instability itself, a 47-person trial with no placebo arm found PRP alone gave the greatest pain reduction, and PRP with exercise or a no-injection manual therapy the broader gains in posture and function. None of these trials shows PRP restoring a loose ligament: it belongs inside the rehab plan. The sprain itself is covered on our ankle sprain page.
Talar cartilage lesions: where PRP and cells sit in the reviews
An osteochondral lesion of the talus, damage to the cartilage and bone on top of the ankle bone, is common after even minor trauma. In a 32-patient randomized trial, three PRP injections beat hyaluronic acid on function scores at 28 weeks, though not significantly on pain. In a 2025 review, PRP was most frequently tested as an adjunct to bone marrow stimulation surgery; 4 of 5 of those studies improved pain and function over surgery alone, and only 3 tested PRP as a stand-alone injection. A 2025 meta-analysis of 348 patients found microfracture plus mesenchymal stem cell injection scored better than microfracture alone, and a Level IV review of 11 bone marrow concentrate studies (527 subjects, talar lesions and Achilles ruptures together) reported better function and less pain. So stand-alone PRP has one small randomized trial against hyaluronic acid, the cell evidence is as an add-on to surgery, and whether an injection such as Dynamic Stem Cell+ is a reasonable first step is an exam decision.
Ankle arthritis: the key PRP trial found no benefit over saline
Ankle arthritis, wear of the tibiotalar joint, affects about 3.4% of adults and, in younger patients, is more common than knee or hip arthritis. The key test of PRP for it is a double-blind trial at 6 Dutch sites: 100 patients received two ultrasound-guided injections of PRP or saline. Over 26 weeks the ankle score rose 10 points with PRP and 11 with saline, and the authors wrote that the results do not support PRP for ankle arthritis. At 52 weeks, still no difference. A 2023 systematic review found no clinically relevant benefit, and a 2026 review found no evidence that PRP alone is effective. We take that at face value: on this evidence, a PRP injection by itself is not our answer for an arthritic ankle. Where PRP does have support is on our Dynamic PRP+ page.
Cells for the arthritic ankle, and the operations they are measured against
In a nonrandomized study of 31 patients with early or moderate ankle arthritis, micro-fragmented fat (MFAT) improved scores at 6, 12 and 24 months, with some worsening between 12 and 24. A 2024 Level III review of fat-derived cells in the ankle found 8 studies, all with a second procedure alongside, too scarce and low in quality for definitive conclusions. A 2026 review that searched for randomized trials of stem cell injections in ankle arthritis included none. Against that sit the operations: fusion gives up motion, and distraction, the joint-sparing option, failed in 11% of patients overall and 28% of those followed beyond 5 years. On that small nonrandomized evidence, we discuss Dynamic Stem Cell+ as an option for the early to moderate ankle.
Who is a candidate, and who is not
The exam, the ultrasound and your imaging sort the ankle first; the treatment follows.
- An ankle that keeps giving way, in a runner or hiker willing to do the exercise work the trials pair with PRP
- A talar cartilage lesion, or early to moderate arthritis after an old fracture or years of sprains
- Not without an exam: whether an unstable ankle or a cartilage lesion needs an operation is decided after imaging and diagnostic ultrasound
- Not when the arthritis is end-stage with severe deformity: in our judgment, that warrants surgical referral first
Before you book, ask
- Which published trial supports this injection for my kind of ankle, and what was it compared against?
- Are my ligaments intact or failed, and how did you test them?
- If this does not work, what is the surgical option, and does the injection change it?
What you are really asking for
Nobody books this visit for an ankle score. You want the Mesa Trail before work, the fourteener in August, the dog walk without scanning every rock. Saying plainly which ankle you have, and what the evidence does not support, is how we try to buy back that time instead of spending it on an injection that was not going to help.
Frequently asked questions
Does PRP work for ankle arthritis?
Not on current evidence. In a double-blind trial published in JAMA in 2021, 100 patients with ankle arthritis at 6 Dutch sites received two ultrasound-guided injections of PRP or saline. Over 26 weeks the ankle score improved 10 points with PRP and 11 with saline, and the authors concluded the results do not support PRP for ankle arthritis. The 52-week follow-up found no difference either. Smaller pooled reviews report short-term gains, but a 2023 meta-analysis judged their size similar to the placebo effect in that trial. On this evidence, a PRP injection by itself is not our answer for an arthritic ankle.
Can PRP help an ankle sprain or chronic ankle instability?
The evidence is mixed, and none of the trials we cite shows PRP restoring a loose ligament. In a 2026 trial of 47 people with chronic ankle instability and no placebo arm, PRP alone gave the greatest pain drop, and PRP with exercise or a no-injection manual therapy gave broader gains in posture and function. In a 2023 trial of 40 patients, PRP added after ligament repair surgery did no better than standard care. In a 2026 study of 40 athletes after an acute sprain, PRP did not improve pain, function or overall return to sport rates; a shorter median time to unrestricted sport, 14.5 against 17.8 weeks, was exploratory.
What are the alternatives to ankle fusion?
For some ankles, for a time. Fusion is the gold standard for late-stage ankle arthritis, a 2023 review notes, but it gives up range of motion; distraction, a joint-sparing operation in an external frame, failed in 28% of patients followed beyond 5 years. Among injections, a 2026 review of randomized trials judged hyaluronic acid the most effective, on little research, and found no evidence for PRP alone. We offer hyaluronic acid paired with PRP, never on its own. For an early to moderate ankle, we discuss Dynamic Stem Cell+ as an option on small nonrandomized evidence. In our judgment, end-stage arthritis with severe deformity warrants surgical referral. When surgery is the right answer, we coordinate.
Does PRP help an osteochondral lesion of the talus?
Some, largely as an add-on to surgery. In a 32-patient randomized trial, three PRP injections improved function more than hyaluronic acid over 28 weeks, though the pain difference was not significant. A 2024 meta-analysis of 5 randomized trials with 198 patients found PRP added to microfracture reduced pain and improved function more than microfracture alone. A 2024 meta-analysis of ankle PRP trials found no significant overall difference in ankle scores; a subgroup only suggested PRP may be more effective in talar cartilage injuries than in other ankle conditions. The trials are small, and a 2025 review found PRP studies of these lesions poorly reported. Whether a lesion needs surgery is an exam decision.
How successful is stem cell therapy for ankle arthritis?
The evidence is early, and the reviews we cite include no randomized trial that gives a success rate. In a nonrandomized study of 31 patients with early or moderate ankle arthritis, an injection of micro-fragmented fat improved pain and function scores at 6, 12 and 24 months, with some worsening from 12 to 24 months. A 2024 review of fat-derived cells in the ankle found 8 studies, all with a second procedure alongside, and judged them too scarce and low in quality for definitive conclusions. A 2026 review of randomized injection trials in ankle arthritis found none testing stem cells. Dynamic Stem Cell+ is an option we discuss for the early to moderate ankle, not a promise.
What are the downsides of PRP or stem cell injections in the ankle?
The first is side effects. A 2025 review of randomized foot and ankle trials found treatment-site pain in 15.1% of PRP patients against 10.2% after comparison treatments, and estimated that 13 patients need PRP for one to have a complication over an alternative injection; one patient needed surgery for severe pain after an Achilles injection. In the fat-derived cell studies in the ankle, no serious complications were reported. The second is the evidence: for ankle arthritis, PRP alone did not beat saline, and the cell studies are small. The third is cost: PRP, BMA and MFAT are out of pocket. We go through each with you before any injection.
What is recovery like after a PRP or stem cell injection in the ankle?
Neither is surgery. After Dynamic PRP+, most active adults return to daily activity within days and to sport within weeks, depending on the tissue treated. Dynamic Stem Cell+ is a non-surgical, in-office procedure: most patients return to daily activity quickly and follow specific activity guidance during the early healing phase. For an unstable ankle, the injection sits inside a balance and strength program, because rehab restores control.
How long is the visit, and how much do ankle injections cost?
The new patient appointment is 90 minutes: the exam, a ligament check, a review of your imaging and a plan. A Dynamic PRP+ injection appointment is about 90 minutes, and a Dynamic Stem Cell+ procedure is 2 to 3 hours. We give a quote after a thorough evaluation. We price the plan for optimal outcomes, not line items off a menu. PRP, BMA and MFAT are out of pocket; Medicare and Kaiser are accepted for consultations and office visits only. Care is HSA/FSA eligible, with Cherry financing available.
Find out which ankle you have, before fusion takes the choice
Told it is age? Book the 90-minute evaluation with Aneesh Garg, DO, CAQ. He examines the ankle, tests the ligaments and reviews your imaging, and tells you whether PRP or stem cells have any evidence for your ankle, and what the options are before fusion.
Book an Evaluation
1790 30th Street Suite 270 · Boulder, CO 80301 · 303-997-1733